Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathee Till

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Molecular Carcinogenesis|January 11, 2018
Circadian genes and risk of prostate cancer in the prostate cancer prevention trialLisa W Chu, Cathee Till, Baiyu Yang, et al.
Cancer Causes & Control : CCC|November 1, 2014
Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention TrialSiobhan Sutcliffe, Cathee Till, Frank J Jenkins, et al.
Breast Cancer Research and Treatment|August 31, 2018
Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927)Sherry Shen, Joseph M Unger, Katherine D Crew, et al.
The Journal of Urology|February 13, 2014
Statin drug use is not associated with prostate cancer risk in men who are regularly screenedElizabeth A Platz, Catherine M Tangen, Phyllis J Goodman, et al.
Cancer Causes & Control : CCC|November 22, 2015
Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention TrialJeannette M Schenk, Cathee Till, Ann W Hsing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2015
Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927Dawn L Hershman, Joseph M Unger, Katherine D Crew, et al.
Cancer Causes & Control : CCC|July 20, 2012
Prospective study of cytomegalovirus serostatus and prostate cancer risk in the Prostate Cancer Prevention TrialSiobhan Sutcliffe, Cathee Till, Charlotte A Gaydos, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 16, 2014
Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention TrialAlan R Kristal, Cathee Till, Xiaoling Song, et al.
Urology|May 15, 2014
Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results From the Prostate Cancer Prevention TrialWilliam D Figg, Cindy H Chau, Douglas K Price, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 15, 2013
Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trialMarian L Neuhouser, Elizabeth A Platz, Cathee Till, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Molecular Carcinogenesis|January 11, 2018
Circadian genes and risk of prostate cancer in the prostate cancer prevention trialLisa W Chu, Cathee Till, Baiyu Yang, et al.
Cancer Causes & Control : CCC|November 1, 2014
Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention TrialSiobhan Sutcliffe, Cathee Till, Frank J Jenkins, et al.
Breast Cancer Research and Treatment|August 31, 2018
Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927)Sherry Shen, Joseph M Unger, Katherine D Crew, et al.
The Journal of Urology|February 13, 2014
Statin drug use is not associated with prostate cancer risk in men who are regularly screenedElizabeth A Platz, Catherine M Tangen, Phyllis J Goodman, et al.
Cancer Causes & Control : CCC|November 22, 2015
Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention TrialJeannette M Schenk, Cathee Till, Ann W Hsing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2015
Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927Dawn L Hershman, Joseph M Unger, Katherine D Crew, et al.
Cancer Causes & Control : CCC|July 20, 2012
Prospective study of cytomegalovirus serostatus and prostate cancer risk in the Prostate Cancer Prevention TrialSiobhan Sutcliffe, Cathee Till, Charlotte A Gaydos, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 16, 2014
Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention TrialAlan R Kristal, Cathee Till, Xiaoling Song, et al.
Urology|May 15, 2014
Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results From the Prostate Cancer Prevention TrialWilliam D Figg, Cindy H Chau, Douglas K Price, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 15, 2013
Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trialMarian L Neuhouser, Elizabeth A Platz, Cathee Till, et al.
Pageof 7